Canadian cannabis sales up 20% in Q2 2025 as licensed area expands

The latest sales and inventory figures from Health Canada indicate that total cannabis sales in the medical and recreational markets were up 20% in Q2 2025 (April-June) compared with June 2024.

Dried cannabis continued to account for the largest share of total medical and non-medical sales at 50% (12,901,920 units). This was followed by edible cannabis and cannabis extracts, each at 25%.

Packaged inventory was up 10% from June 2024. Dried cannabis also had the largest share of packaged inventory at 41% (36,024,728 units), followed by cannabis edibles and extracts, each at 29%.

Total packaged inventory held by federal licence holders and provincial distributors/retailers fluctuated, with provincial distributors and retailers holding 38,654,087 units in June 2025. Total sales (medical and non-medical combined) for June 2025 reached 25,825,820 units.

The destruction of unpackaged dried cannabis as a share of production has generally been decreasing, falling from 41% in Q1 2023 to just 10.4% in Q2 2025.

Total Licensed Area:

As of January 2025, Health Canada’s quarterly figures no longer provide detailed inventory and sales data for each product category. All figures for dried cannabis, edible cannabis, cannabis extracts, cannabis topicals, cannabis plants, cannabis seeds, and licensed area and employment info through 2024 are now archived.

These figures are reported under the Cannabis Tracking System Order and come from Health Canada’s “Cannabis data overview: Inventory, sales and licensed area,” which provides detailed data on the legal cannabis industry.